Barclays might receive cash infusion

Barclays PLC might receive about $927 million from Sumitomo Mitsui Financial Group Inc. to bolster its depleted balance sheet.
JUN 20, 2008
Barclays PLC might receive about 100 billion yen ($927 million) from Sumitomo Mitsui Financial Group Inc. of Tokyo as part of a plan to add capital to its depleted balance sheet, a person with knowledge of the plan told Bloomberg. Sumitomo Mitsui, will make the investment through its Sumitomo Mitsui Banking Corp. unit, the person said, declining to be identified because the deal hasn't been completed. Representatives of Sumitomo Mitsui Banking of Tokyo and Barclays declined to comment in the report. London-based Barclays, which has been hit with 1.77 billion pounds ($3.35 billion) of write-downs, said earlier in the week it might sell stock to existing shareholders and try to raise capital overseas, Bloomberg reported. Sumitomo Mitsui's stake would amount to about 2.3% of the bank's share capital, based on Barclays's Thursday closing price of $25.57. Barclays also may get investments from current shareholders Temasek Holdings of Singapore and China Development Bank of Beijing, analysts at NCB Stockbrokers Ltd. of London told Bloomberg. Under the terms of the agreement, Barclays and Sumitomo Mitsui will work together on projects in Asia, said the person who declined to be identified. The companies may announce their deal by the end of June, the person said.

Latest News

Retiree alleges advisor withheld $600K through real estate LLC web
Retiree alleges advisor withheld $600K through real estate LLC web

$1.7M invested from an inheritance. Then the phone went dead.

SEC accuses Linqto chiefs of 'Wizard of Oz' investor deception
SEC accuses Linqto chiefs of 'Wizard of Oz' investor deception

The pre-IPO platform sold $430M in units while allegedly rigging prices behind the scenes.

GLP-1 users are trading retirement savings for their prescriptions
GLP-1 users are trading retirement savings for their prescriptions

A Nationwide survey finds 47% of GLP-1 users have never discussed the drugs’ financial impact with an advisor, even as many dip into savings.

Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors
Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors

The hundreds of millions of dollars from a sale of Inspired Healthcare properties does not mean an immediate windfall for investors.

Class action alleges Webull misled investors about China operations
Class action alleges Webull misled investors about China operations

Its SEC filings said one thing - a congressional probe said another.

SPONSORED Built on insurance experience to deliver on long-term promises

Knighthead Life entered the market with a competitive MYGA. A strong launch earned advisor confidence and paved the way for FIAs.

SPONSORED In the Age of AI, Trust Becomes the Advisor's Greatest Asset

As AI makes financial information more accessible than ever, Lana Hock explains why human judgment, trust, and empathy remain the qualities clients value most in a financial advisor